{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:01:43Z","timestamp":1794045703116,"version":"4.8.0"},"reference-count":10,"publisher":"BMJ","issue":"11","license":[{"start":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T00:00:00Z","timestamp":1727222400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Research and Innovation Program","award":["681031"],"award-info":[{"award-number":["681031"]}]},{"name":"NWO","award":["16447"],"award-info":[{"award-number":["16447"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Thorax"],"published-print":{"date-parts":[[2024,11]]},"abstract":"<jats:p>Mesenchymal stem cells (MSC) have immune regulatory properties that may ameliorate pathophysiological processes in sepsis. We determined the effect of allogeneic adipose-derived MSCs (Cx611) on the host response during sepsis due to community-acquired bacterial pneumonia (CABP) by measuring 29 plasma biomarkers and blood transcriptomes at six time points in 82 patients randomised to two intravenous infusions of Cx611 or placebo. Cx611 treatment enhanced several endothelial cell and procoagulant response plasma biomarkers, and led to increased expression of pathways related to innate immunity, haemostasis and apoptosis. Cx611 infusion in sepsis due to CABP is associated with broad host response alterations.<\/jats:p>","DOI":"10.1136\/thorax-2024-222026","type":"journal-article","created":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T17:20:21Z","timestamp":1727284821000},"page":"1086-1090","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":11,"title":["Effect of mesenchymal stem cells on the host response in severe community-acquired pneumonia"],"prefix":"10.1136","volume":"79","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1764-0114","authenticated-orcid":false,"given":"Tom D Y","family":"Reijnders","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Fran\u00e7ois","family":"Laterre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Fran\u00e7ois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"S\u00e1nchez Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tjitske S R","family":"van Engelen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daoud","family":"Sie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendon P","family":"Scicluna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmitry V","family":"Ostanin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin J","family":"Galinsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joe M","family":"Butler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleuterio","family":"Lombardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9199-5079","authenticated-orcid":false,"given":"Tom","family":"van der Poll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2024,9,25]]},"reference":[{"key":"2024101604001475000_79.11.1086.1","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00064-21","article-title":"Mesenchymal Stromal Cells: an Antimicrobial and Host-Directed Therapy for Complex Infectious Diseases","volume":"34","author":"Shaw","year":"2021","journal-title":"Clin Microbiol Rev"},{"key":"2024101604001475000_79.11.1086.2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13054-022-04287-4","article-title":"The safety and efficacy of mesenchymal stromal cells in ARDS: a meta-analysis of randomized controlled trials","volume":"27","author":"Wang","year":"2023","journal-title":"Crit Care"},{"key":"2024101604001475000_79.11.1086.3","doi-asserted-by":"crossref","first-page":"2","DOI":"10.2991\/icres.k.210622.001","article-title":"Mesenchymal Stem Cells in Sepsis: From Basic Research to Clinical Application","volume":"1","author":"Sun","year":"2021","journal-title":"ICRES"},{"key":"2024101604001475000_79.11.1086.4","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1186\/s12890-020-01324-2","article-title":"A phase Ib\/IIa, randomised, double-blind, multicentre trial to assess the safety and efficacy of expanded Cx611 allogeneic adipose-derived stem cells (eASCs) for the treatment of patients with community-acquired bacterial pneumonia admitted to the intensive care unit","volume":"20","author":"Laterre","year":"2020","journal-title":"BMC Pulm Med"},{"key":"2024101604001475000_79.11.1086.5","doi-asserted-by":"crossref","first-page":"154446","DOI":"10.1016\/j.jcrc.2023.154446","article-title":"The safety and efficacy of stem cells for the treatment of severe community-acquired bacterial pneumonia: A randomized clinical trial","volume":"79","author":"Laterre","year":"2024","journal-title":"J Crit Care"},{"key":"2024101604001475000_79.11.1086.6","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1097\/CCM.0000000000003657","article-title":"Effects of Mesenchymal Stem Cell Treatment on Systemic Cytokine Levels in a Phase 1 Dose Escalation Safety Trial of Septic Shock Patients","volume":"47","author":"Schlosser","year":"2019","journal-title":"Crit Care Med"},{"key":"2024101604001475000_79.11.1086.7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13287-022-02920-1","article-title":"Mesenchymal stromal cell therapy for COVID-19-induced ARDS patients: a successful phase 1, control-placebo group, clinical trial","volume":"13","author":"Kaffash Farkhad","year":"2022","journal-title":"Stem Cell Res Ther"},{"key":"2024101604001475000_79.11.1086.8","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S2213-2600(18)30418-1","article-title":"Treatment with allogeneic mesenchymal stromal cells for moderate to severe acute respiratory distress syndrome (START study): a randomised phase 2a safety trial","volume":"7","author":"Matthay","year":"2019","journal-title":"Lancet Respir Med"},{"key":"2024101604001475000_79.11.1086.9","doi-asserted-by":"crossref","first-page":"S164","DOI":"10.1097\/TA.0000000000001485","article-title":"Procoagulant activity of human mesenchymal stem cells","volume":"83","author":"Christy","year":"2017","journal-title":"J Trauma Acute Care Surg"},{"key":"2024101604001475000_79.11.1086.10","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1093\/stmcls\/sxad087","article-title":"Procoagulant Properties of Mesenchymal Stem Cells and Extracellular Vesicles: a Novel Aspect of Thrombosis Pathogenesis","volume":"42","author":"Yang","year":"2024","journal-title":"Stem Cells"}],"container-title":["Thorax"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/thorax-2024-222026","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T18:24:37Z","timestamp":1729103077000},"score":1,"resource":{"primary":{"URL":"https:\/\/thorax.bmj.com\/lookup\/doi\/10.1136\/thorax-2024-222026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,25]]},"references-count":10,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2024,10,16]]},"published-print":{"date-parts":[[2024,11]]}},"alternative-id":["10.1136\/thorax-2024-222026"],"URL":"https:\/\/doi.org\/10.1136\/thorax-2024-222026","relation":{},"ISSN":["0040-6376","1468-3296"],"issn-type":[{"value":"0040-6376","type":"print"},{"value":"1468-3296","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,25]]}}}